标题
Current recommendations for chelation for transfusion-dependent thalassemia
作者
关键词
-
出版物
Annals of the New York Academy of Sciences
Volume 1368, Issue 1, Pages 107-114
出版商
Wiley
发表日期
2016-05-17
DOI
10.1111/nyas.13088
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients
- (2015) E. Cassinerio et al. ANNALS OF HEMATOLOGY
- Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
- (2015) Yesim Aydinok et al. BLOOD
- Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients
- (2015) Mohsen S. Elalfy et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study
- (2015) Sidharth Totadri et al. PEDIATRIC BLOOD & CANCER
- MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients
- (2014) Diana X. Nichols-Vinueza et al. AMERICAN JOURNAL OF HEMATOLOGY
- Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine
- (2014) Dudley J. Pennell et al. AMERICAN JOURNAL OF HEMATOLOGY
- A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in -thalassemia major (CORDELIA)
- (2014) D. J. Pennell et al. BLOOD
- Combination of deferasirox and deferoxamine in clinical practice: An alternative scheme of chelation in thalassemia major patients
- (2014) E. Cassinerio et al. BLOOD CELLS MOLECULES AND DISEASES
- Deferasirox for cardiac siderosis in β-thalassaemia major: a multicentre, open label, prospective study
- (2014) Antonio Piga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment
- (2013) F. Danjou et al. BLOOD CELLS MOLECULES AND DISEASES
- Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major
- (2013) Raffaella Origa et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort
- (2012) J. L. Kwiatkowski et al. BLOOD
- Combined chelation therapy with deferasirox and deferoxamine in thalassemia
- (2012) Ashutosh Lal et al. BLOOD CELLS MOLECULES AND DISEASES
- Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with -thalassemia major
- (2012) D. J. Pennell et al. HAEMATOLOGICA
- Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications
- (2011) Kallistheni Farmaki et al. BLOOD CELLS MOLECULES AND DISEASES
- The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores
- (2010) J. C. Wood et al. BLOOD
- Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging
- (2010) A. Pepe et al. HAEMATOLOGICA
- Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia
- (2010) Hsiu-Hao Chang et al. PEDIATRIC BLOOD & CANCER
- Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone
- (2010) Patricia Evans et al. Translational Research
- Efficacy of deferasirox in reducing and preventing cardiac iron overload in -thalassemia
- (2009) D. J. Pennell et al. BLOOD
- Deferasirox pharmacokinetics in patients with adequate versus inadequate response
- (2009) D. Chirnomas et al. BLOOD
- Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major
- (2009) Kallistheni Farmaki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major
- (2009) P. Kirk et al. CIRCULATION
- Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study
- (2009) Ali Taher et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Effect of transfusional iron intake on response to chelation therapy in -thalassemia major
- (2007) A. R. Cohen et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More